Strategic Partnerships GenTegra has active distribution partnerships with Trajan Scientific and Medical and collaborative ties with Thorne HealthTech, indicating a channel-driven sales path for expanding market reach and co-branded solutions in RNA and DNA stabilization products.

Target Markets Current focus on ambient temperature stabilization for DNA, RNA, and biospecimens positions GenTegra to upsell to biobanks, clinical laboratories, and research institutions seeking cost-effective cold-chain alternatives and robust sample protection.

Product Expansion Recent and ongoing development of whole blood DNA collection kits and RNAdvantage RNA stabilization lines suggests opportunities to cross-sell to organizations investing in next-generation collection and processing workflows.

Industry Trends Growing demand for ambient storage and secure transport of biomolecules aligns GenTegra with markets pursuing decentralized sampling, remote collection, and large-volume biobanking, offering a competitive edge through stable, easy-to-use solutions.

Smaller Customer Target With a small employee base but notable partnerships and a revenue range of one to ten million, GenTegra can efficiently pursue mid-market accounts, universities, CROs, and diagnostic developers that require specialized stabilization tech without large-scale procurement barriers.